BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target
Benzinga Newsdesk 5 months ago
NewsPrice TargetReiterationAnalyst Ratings
BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintains $1 price target.
BTIG analyst Ryan Zimmerman reiterates Xtant Medical Holdings (AMEX:XTNT) with a Buy and maintains $1 price target.